Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression
A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort
- To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
- To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Descrizione dettagliata
This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Muxuan Chen, Doctor
- Numero di telefono: +8613580561916
- Email: muxuanchen@126.com
Luoghi di studio
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Cina
- Peking University First Hospital
-
Contatto:
- Bingbing Xiao, Doctor
-
-
Fujian
-
Fuzhou, Fujian, Cina
- Fujian Maternity and Child Health Hospital
-
-
Gansu
-
Lanzhou, Gansu, Cina
- The First Hospital of Lanzhou University
-
Contatto:
- Haitao Yu, Doctor
-
Lanzhou, Gansu, Cina
- Gansu Provincial Hospital
-
Contatto:
- Lianhua Wei, Doctor
-
-
Guangdong
-
Chaozhou, Guangdong, Cina
- Chaozhou Central Hospital
-
Contatto:
- Fen lin, Doctor
-
Foshan, Guangdong, Cina
- Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
-
Contatto:
- Chaoxin Jiang, Doctor
-
Guangzhou, Guangdong, Cina
- The First Affiliated Hospital, Sun Yat-sen University
-
Contatto:
- Bin Huang, Doctor
-
Guangzhou, Guangdong, Cina
- Nanfang Hospital, Southern Medical University
-
Contatto:
- Dehua Sun, Doctor
-
Guangzhou, Guangdong, Cina
- The Fifth Affiliated Hospital of Southern Medical University
-
Contatto:
- Xiaoyan Li, Doctor
-
Guangzhou, Guangdong, Cina
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Contatto:
- Yingchun Zhou, Doctor
-
Guangzhou, Guangdong, Cina
- The Fifth Affiliated Hospital of Guangzhou Medical University
-
Contatto:
- Liang Peng, Doctor
-
Guangzhou, Guangdong, Cina
- The Third Affiliated Hospital of Southern Medical University
-
Contatto:
- Xuefeng Wang, Doctor
-
Guangzhou, Guangdong, Cina
- The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
-
Contatto:
- Kewei Zhao, Doctor
-
Guangzhou, Guangdong, Cina
- Zhujiang Hospital of Southern Medical University
-
Guangzhou, Guangdong, Cina
- Guangzhou Baiyun District Taihe People's Hospital
-
Huizhou, Guangdong, Cina
- Huizhou Municipal Central Hospital
-
Contatto:
- Xianjin Wu, Doctor
-
Shaoguan, Guangdong, Cina
- Yuebei People's Hospital
-
Contatto:
- Pingsen Zhao, Doctor
-
Shenzhen, Guangdong, Cina, 518028
- Shenzhen Maternity & Child Healthcare Hospital
-
Contatto:
- Yuting Dai
- Numero di telefono: 0755-82869849
-
Shenzhen, Guangdong, Cina
- Luohu District People's Hospital
-
Shenzhen, Guangdong, Cina
- Southern Medical University Shenzhen Hospital
-
Contatto:
- Hongwei Zhou, Doctor
-
Shenzhen, Guangdong, Cina
- The Seventh Affiliated Hospital, Sun Yat-sen University
-
Contatto:
- Zhaofan Luo, Doctor
-
Zhongshan, Guangdong, Cina
- Zhongshan Xiaolan People's Hospital
-
Contatto:
- Wandang Wang, Doctor
-
Zhuhai, Guangdong, Cina
- Zhuhai Maternal and Child Health Hospital
-
-
Guangxi
-
Nanning, Guangxi, Cina
- The First Affiliated Hospital of Guangxi Medical University
-
Contatto:
- Faquan Lin, Doctor
-
-
Guizhou
-
Guiyang, Guizhou, Cina
- Affiliated Hospital of Guizhou Medical University
-
Contatto:
- Fan Lu, Doctor
-
Zunyi, Guizhou, Cina
- Zunyi First People's Hospital
-
Contatto:
- Kaifeng Wu, Doctor
-
-
Hainan
-
Haikou, Hainan, Cina
- Hainan General Hospital
-
Contatto:
- Bo Wang, Doctor
-
-
Heilongjiang
-
Mudanjiang, Heilongjiang, Cina
- Hongqi Hospital Affiliated to Mudanjiang Medical University
-
Contatto:
- Chunxia Guo, Doctor
-
Qiqihar, Heilongjiang, Cina
- Qiqihar First Hospital
-
-
Henan
-
Zhengzhou, Henan, Cina
- Henan Provincial People's Hospital
-
Contatto:
- Jing Zhao, Doctor
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, Cina
- Inner Mongolia Autonomous Region Maternal and Child Health Hospital
-
Contatto:
- Jing Sha, Doctor
-
-
Jiangsu
-
Lianyungang, Jiangsu, Cina
- The Second People's Hospital of Lianyungang
-
Contatto:
- Wei Liang, Doctor
-
-
Jilin
-
Jilin City, Jilin, Cina
- Jilin City Central Hospital
-
Contatto:
- Guijie Zhang, Doctor
-
-
Liaoning
-
Shenyang, Liaoning, Cina
- The First Hospital of China Medical University
-
Contatto:
- Ruizhe Wang, Doctor
-
-
Ningxia
-
Yinchuan, Ningxia, Cina
- General Hospital of Ningxia Medical University
-
Contatto:
- Feng Li, Doctor
-
-
Qinghai
-
Xining, Qinghai, Cina
- Qinghai Red Cross Hospital
-
Contatto:
- Dengyun Ma, Doctor
-
-
Shandong
-
Jinan, Shandong, Cina
- Jinan Central Hospital
-
Contatto:
- Shuyi Han, Doctor
-
Jinan, Shandong, Cina
- Shandong Provincial Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Cina
- Shanghai East Hospital, Tongji University
-
Contatto:
- Jingxin Cheng, Doctor
-
-
Shanxi
-
Changzhi, Shanxi, Cina
- Changzhi People's Hospital
-
Contatto:
- Guoxiang Zhang, Doctor
-
-
Sichuan
-
Dazhou, Sichuan, Cina
- Dazhou Integrated Traditional Chinese and Western Medicine Hospital
-
Contatto:
- Xuesu He, Doctor
-
Luzhou, Sichuan, Cina
- Affiliated Hospital of Southwest Medical University
-
Contatto:
- Jinbo Liu, Doctor
-
-
Tibet
-
Lhasa, Tibet, Cina
- Tibet Autonomous Region People's Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.
Descrizione
Inclusion Criteria:
- Female aged 18 to 60 years.
- Participants who previously participated in the baseline of the CALM2004 study.
- Volunteers who are recruited through targeted invitations and consent to participate in this study.
Exclusion Criteria:
- Pregnant women.
- Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
- Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
|---|
|
CALM2004 Follow-up Cohort
A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cumulative incidence of CIN2+ at 5 years
Lasso di tempo: 5 years
|
The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline |
5 years
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
New incidence and progression rates of ASC-US+ cytological abnormalities
Lasso di tempo: 5 years
|
ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology. |
5 years
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Lasso di tempo: 5 years
|
HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up. |
5 years
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Cattedra di studio: Hongwei Zhou, Doctor, Shenzhen Hospital of Southern Medical University
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- CALM2004-5
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .